International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
Frontiers | High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis
Providence Health Care Test Catalog
JPM | Free Full-Text | Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
Immunoglobulin classes
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
British Journal of Haematology | Wiley Online Library
Guide to Antibody structure and isotypes | Abcam
Living With - HealthTree for Multiple Myeloma
Immunoglobulin Kappa Chain - an overview | ScienceDirect Topics
Antibodies gone bad – the molecular mechanism of light chain amyloidosis - Absmeier - 2023 - The FEBS Journal - Wiley Online Library
Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Evaluation of monoclonal gammopathies - Differential diagnosis of symptoms | BMJ Best Practice US